|
| Glaxo wins FDA approval for wider Advair use |
30 Apr 08, 21:53 |
|
| U.S. health regulators have said GlaxoSmithKline Plc's Advair is safe and effective to more widely treat patients with chronic obstructive pulmonary disease (COPD), the drugmaker said on Wednesday. |
| more |
|
